Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
Richard Williams, Former CHRO at Western Union: How HR Becomes a Board-Level Power Function
Richard Williams, Board Mentor at Criticaleye and former Chief Human Resources Officer (CHRO) at Western Union joins Bridgette Hall, Senior Editor at Criticaleye to explore what it takes to lead HR in a global organi...
VIEWPOINTS | The Sustainability Reset
There’s no doubt that the external narrative around sustainability has shifted over the last 18 months, but behind the scenes companies continue to navigate the challenges and opportunities associated with the ...
BLOG | Transforming Your Sustainability Strategy
Sustainability remains firmly on the agenda for most organisations, but the way leaders are approaching it is changing. What used to be driven by bold, standalone commitments are now shifting towards a more grounded ...
Displaying 1 to 3 of 201
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
